explore -WSS

explore

author：entertainment 2025-09-03 14:43:09 - browse：63475

Beam Therapeutics said Thursday morning it would lay off 20% of its staff — or around 100 employees — and pause or reevaluate certain programs as it looks to cut costs.

It’s a notable setback for a gene-editing company that quickly raised over $1 billion in the few years after its co-founder, David Liu, described a new form of CRISPR, called base editing, that allowed researchers to change individual letters of DNA. The biotech hired rapidly, announced its intention to treat a broad range of diseases, and received clearance to start clinical trials in cancer and sickle cell.

Beam, however, has struggled to enroll patients in those trials. Meanwhile, the biotech stock market has stayed cold, including for gene-editing companies, whose technologies raise new regulatory, safety, and reimbursement questions. The pending approval of two gene therapies for sickle cell would also limit the market for Beam’s lead drug.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Hepatitis C has a cure — but many Americans still lack access to it
Next article： Florida babysitter arrested over hot car death, authorities say

WSS

Grad students accuse University of California of wage theft

People with substance use disorder deserve online privacy

Suspects arrested after 3 women attacked on Manhattan's West Side: Police

What is the Turing Test that determines if computers can think?

Chamber of Commerce, DOJ clash in court over drug prices

Prosecutors say FTX founder Sam Bankman

hotspot

explore

knowledge

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

Family of Gilgo Beach murder suspect releases statement: 'Devastating time'

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Why the quest to eradicate polio has stumbled

Guidelines to prevent youth baseball injuries need more muscle

Prosecutors say FTX founder Sam Bankman

New air purifier tech could be key to improving indoor air quality

Midwives could help bridge maternal health disparities in the U.S.

DIEP, the 'gold standard' of breast reconstruction, is under threat

Information blocking fines are now fair game in health care

hotspot

Listen: BridgeBio's big week & Lilly's Alzheimer's data

'A game

Why the advice to take all your antibiotics may be wrong

A new deal aims to ramp up use of AI in rehab care decisions

FDA weighs limits of animal data in assessing artificial wombs

Trump Organization, Michael Cohen agree to settle million

entertainment

entertainment

Wikipedia

entertainment